Molecular Stethoscope
South San Francisco, United States · Founded 2014 · $8.2M raised
- Headquarters
- South San Francisco, California
- Founded
- 2014
- Business Model
- B2B
- Total Funding
- $8.2M
- Last Round
- $8.2M Series ADec 2023
- Rounds
- 2
About
Molecular Stethoscope was a South San Francisco-based molecular diagnostics company that developed liquid biopsy tests using cell-free RNA to assess tissue and organ health non-invasively. Founded in 2014, the company pioneered cfRNA profiling approaches applicable to cancer detection and organ monitoring. The company later evolved into Superfluid Diagnostics (Superfluid Dx), continuing its liquid biopsy work.
Summary
Molecular Stethoscope is a Biotech company based in South San Francisco, United States, founded in 2014. It has raised $8.2M in total across 2 rounds, most recently a $8.2M Series A round in Dec 2023. Investors include DCVC (Data Collab), Pfizer Ventures and Index Ventures.
Funding History
Dec 2023
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/molecular-stethoscope"><img src="https://indexed.vc/api/badge/company/molecular-stethoscope" alt="Molecular Stethoscope on Indexed.vc" width="260" height="76" /></a>